Key result
Fibrinolysis increasingly replaces urgent surgery as first-line therapy for prosthetic valve thrombosis.
Why the study?
Prosthetic valve thrombosis is a life-threatening complication of mechanical heart valves, and its management remains challenging with ongoing debate between surgical and thrombolytic approaches.
Does fibrinolytic therapy compared to urgent surgery improve outcomes in patients with prosthetic valve thrombosis?
Does fibrinolytic therapy compared to urgent surgery improve outcomes in patients with prosthetic valve thrombosis?
Contemporary evidence supports a shift from urgent surgery to individualized treatment strategies, with fibrinolysis increasingly used as a first-line option for left-sided mechanical prosthetic valve thrombosis.
Answers are grounded in this paper and cite their sources.
Updates PVT management guidance amid surgical-thrombolysis debate; extends RCT and observational synthesis for practice and trials.
INTRODUCTION: Prosthetic valve thrombosis (PVT) is a serious and potentially life-threatening complication of mechanical heart valves. Management remains challenging, with ongoing debate between surgical and thrombolytic approaches. AREAS COVERED: This review outlines current approaches to the diagnosis and management of PVT, drawing on evidence from observational studies and randomized trials. Literature was identified through a PubMed search covering publications from inception to March 2026, supplemented by manual review of references from relevant articles and major guideline documents. We discuss the role of echocardiography and other imaging modalities in diagnosis and decision-making. The available data comparing surgery and thrombolysis are reviewed, including outcomes with older thrombolytic agents as well as newer low-dose, slow-infusion protocols. Recent trials, including SAFE-PVT and TENET, are also considered in the context of contemporary practice. EXPERT OPINION: The management of prosthetic valve thrombosis (PVT) has undergone a fundamental transformation over the past two decades. Historically, urgent surgery was considered the default treatment for most patients with left-sided mechanical prosthetic valve thrombosis, while fibrinolytic therapy was reserved for those deemed unsuitable for surgery or treated in centers lacking surgical expertise. Contemporary evidence challenges this paradigm. Improvements in multimodality imaging, standardized thrombolytic protocols, and better patient selection have shifted clinical practice toward a more individualized treatment strategy in which fibrinolysis is increasingly considered a first-line option for many patients.
No takes yet. Share an insight, caveat, or question.
Mantoo et al. (2026) conducted a review in Prosthetic valve thrombosis. Fibrinolytic therapy vs. Surgery was evaluated. Fibrinolysis is increasingly considered a first-line option for many patients with prosthetic valve thrombosis, shifting away from urgent surgery as the default treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: